OP12. BRAIN UK, THE NATIONAL BRAIN TUMOUR BANK NETWORK THREE YEARS ON
INTRODUCTION: Brain tumour tissue can be difficult for researchers to access, yet National Health Service (NHS) Neuropathology archives contain a wealth of tissue. A review of NHS CNS biopsy archives revealed around 400,000 stored samples, accruing a further 18,500 annually. Simply trying to identif...
Saved in:
Published in: | Neuro-oncology (Charlottesville, Va.) Vol. 19; no. suppl_1; p. i27 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
US
Oxford University Press
01-01-2017
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | INTRODUCTION: Brain tumour tissue can be difficult for researchers to access, yet National Health Service (NHS) Neuropathology archives contain a wealth of tissue. A review of NHS CNS biopsy archives revealed around 400,000 stored samples, accruing a further 18,500 annually. Simply trying to identify suitable tissue to help shape a study can pose challenges. In addition, the legal and ethical considerations required for approval to use human tissue can be difficult to new researchers and can prove time consuming. METHOD: BRAIN UK is a collaborative national virtual brain bank, facilitating access to under-utilised neuropathology archives for research. Initially funded by the MRC to facilitate access to post-mortem archives and two and half years ago expanded to include biopsies; supported by a group of brain tumour charities led by the brainstrust. 27/30 NHS Neuropathology centres and the Corsellis Collection participate in BRAIN UK, giving effective coverage of over 90% of UK population. A linked-anonymised database includes diagnosis and simple demographics. There is a centralised application process www.brain-uk.org. BRAIN UK acts as a “matchmaker” and its generic ethical approval covers the majority of projects. Investigators’ grants fund the costs associated with the retrieval, processing and transportation of tissue. RESULTS: BRAIN UK utilises its generic ethical approval to reduce the time for researchers to achieve ethics; its network to obtain tissue; and its expertise and insight into potentially available tissue to help form scientifically valid studies. 26 tumour applications and 12 informal enquiries have been supported with over 3,000 tissue samples approved for release for research. Studies have encompassed a wide variety of tumour types utilising a number of techniques. Studies utilising large quantities or rare tumour types particularly highlight the success of this approach. CONCLUSION: Archived tissue that would otherwise be unused has supported valuable research. BRAIN UK is completely reliant on the co-operation and support of its Participating Centres. With plans to include a collaboration with UK Biobank, facilitating access to data, and encourage collaborations, BRAIN UK is advancing in to the future with aims to add value to neuroscience research. |
---|---|
ISSN: | 1522-8517 1523-5866 |
DOI: | 10.1093/neuonc/now292.011 |